Cargando…

The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients

Marfan syndrome (MS) is of the most common connective tissue disorders. Although most patients have mutations in the fibrillin-1 gene (FBN1) and more than 1,700 mutations have been described, there are no mutations in less than 10% of patients. Aortic dilation is the most important complication; it...

Descripción completa

Detalles Bibliográficos
Autores principales: Lomelí, Oscar, Pérez-Torres, Israel, Márquez, Ricardo, Críales, Sergio, Mejía, Ana M., Chiney, Claudia, Hernández-Lemus, Enrique, Soto, Maria E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110856/
https://www.ncbi.nlm.nih.gov/pubmed/30246778
http://dx.doi.org/10.3389/fphys.2018.00965
_version_ 1783350553218121728
author Lomelí, Oscar
Pérez-Torres, Israel
Márquez, Ricardo
Críales, Sergio
Mejía, Ana M.
Chiney, Claudia
Hernández-Lemus, Enrique
Soto, Maria E.
author_facet Lomelí, Oscar
Pérez-Torres, Israel
Márquez, Ricardo
Críales, Sergio
Mejía, Ana M.
Chiney, Claudia
Hernández-Lemus, Enrique
Soto, Maria E.
author_sort Lomelí, Oscar
collection PubMed
description Marfan syndrome (MS) is of the most common connective tissue disorders. Although most patients have mutations in the fibrillin-1 gene (FBN1) and more than 1,700 mutations have been described, there are no mutations in less than 10% of patients. Aortic dilation is the most important complication; it involves chronic inflammatory processes and endothelial dysfunction. Prospective study from March 2015 to January 2017, in a cohort of 32 patients of MS confirmed by Ghent criteria and 35 controls of both genders, with a median age of 26 years (18–56). Patients had no comorbidities such as diabetes, hypertension, and/or neoplasms. They were not being treated with statin, NSAIDs, calcium antagonists, oral nitrates, and/or beta-blockers during 7 days prior to the study and patients with smoking history in the last 4 years. Controls were matched by age and gender. We analyzed endothelial dysfunction by flow-mediated vasodilation in the brachial artery, determining the maximum peak flow in the reactive hyperemia phase with a Philips Envisor device with Doppler capability. Its correlation with serum levels of biological markers that could participate in endothelial dysfunction pathways such as [Formula: see text] ratio, [Formula: see text] , citrulline, TNFα, IL-1, IL-6, IL-10, IL-8, osteopontin, ICAM, VCAM, and [Formula: see text] was determined. Endothelial dysfunction was found in 21 MS patients (65%). The aortic annulus (AAo) was of 27 mm (22–40) and 24 mm (22–30) (p = 0.04) in MS patients with and without dysfunction. The level of [Formula: see text] ratio, was of 108.95 ± 12.05 nM/ml in controls vs. 170.04 ± 18.76 nM/ml in MS (p = 0.002), [Formula: see text] was of 33.78 ± 3.41 vs. 43.95 ± 2.59 nM/ml (p = 0.03), citrulline 62.65 ± 3.46 vs. 72.81 ± 4.35 μMol/ml (p = 0.06). VCAM median was 39 pg/ml (0–86) vs. 32 pg/ml (11–66) (p = 0.03), respectively. The correlation of VCAM with triglycerides (TG) was of 0.62 (p = 0.005). There were no differences in TNFα, IL-1, IL-6, IL-8, IL-10, and osteopontin. MS endothelial dysfunction is related to aortic diameters, and increased levels of VCAM, L-citrulline and [Formula: see text] ratio, [Formula: see text]. VCAM-1 has a significant correlation with TG and could play a significant role in endothelial dysfunction.
format Online
Article
Text
id pubmed-6110856
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-61108562018-09-05 The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients Lomelí, Oscar Pérez-Torres, Israel Márquez, Ricardo Críales, Sergio Mejía, Ana M. Chiney, Claudia Hernández-Lemus, Enrique Soto, Maria E. Front Physiol Physiology Marfan syndrome (MS) is of the most common connective tissue disorders. Although most patients have mutations in the fibrillin-1 gene (FBN1) and more than 1,700 mutations have been described, there are no mutations in less than 10% of patients. Aortic dilation is the most important complication; it involves chronic inflammatory processes and endothelial dysfunction. Prospective study from March 2015 to January 2017, in a cohort of 32 patients of MS confirmed by Ghent criteria and 35 controls of both genders, with a median age of 26 years (18–56). Patients had no comorbidities such as diabetes, hypertension, and/or neoplasms. They were not being treated with statin, NSAIDs, calcium antagonists, oral nitrates, and/or beta-blockers during 7 days prior to the study and patients with smoking history in the last 4 years. Controls were matched by age and gender. We analyzed endothelial dysfunction by flow-mediated vasodilation in the brachial artery, determining the maximum peak flow in the reactive hyperemia phase with a Philips Envisor device with Doppler capability. Its correlation with serum levels of biological markers that could participate in endothelial dysfunction pathways such as [Formula: see text] ratio, [Formula: see text] , citrulline, TNFα, IL-1, IL-6, IL-10, IL-8, osteopontin, ICAM, VCAM, and [Formula: see text] was determined. Endothelial dysfunction was found in 21 MS patients (65%). The aortic annulus (AAo) was of 27 mm (22–40) and 24 mm (22–30) (p = 0.04) in MS patients with and without dysfunction. The level of [Formula: see text] ratio, was of 108.95 ± 12.05 nM/ml in controls vs. 170.04 ± 18.76 nM/ml in MS (p = 0.002), [Formula: see text] was of 33.78 ± 3.41 vs. 43.95 ± 2.59 nM/ml (p = 0.03), citrulline 62.65 ± 3.46 vs. 72.81 ± 4.35 μMol/ml (p = 0.06). VCAM median was 39 pg/ml (0–86) vs. 32 pg/ml (11–66) (p = 0.03), respectively. The correlation of VCAM with triglycerides (TG) was of 0.62 (p = 0.005). There were no differences in TNFα, IL-1, IL-6, IL-8, IL-10, and osteopontin. MS endothelial dysfunction is related to aortic diameters, and increased levels of VCAM, L-citrulline and [Formula: see text] ratio, [Formula: see text]. VCAM-1 has a significant correlation with TG and could play a significant role in endothelial dysfunction. Frontiers Media S.A. 2018-08-21 /pmc/articles/PMC6110856/ /pubmed/30246778 http://dx.doi.org/10.3389/fphys.2018.00965 Text en Copyright © 2018 Lomelí, Pérez-Torres, Márquez, Críales, Mejía, Chiney, Hernández-Lemus and Soto. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Lomelí, Oscar
Pérez-Torres, Israel
Márquez, Ricardo
Críales, Sergio
Mejía, Ana M.
Chiney, Claudia
Hernández-Lemus, Enrique
Soto, Maria E.
The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title_full The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title_fullStr The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title_full_unstemmed The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title_short The Evaluation of Flow-Mediated Vasodilation in the Brachial Artery Correlates With Endothelial Dysfunction Evaluated by Nitric Oxide Synthase Metabolites in Marfan Syndrome Patients
title_sort evaluation of flow-mediated vasodilation in the brachial artery correlates with endothelial dysfunction evaluated by nitric oxide synthase metabolites in marfan syndrome patients
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110856/
https://www.ncbi.nlm.nih.gov/pubmed/30246778
http://dx.doi.org/10.3389/fphys.2018.00965
work_keys_str_mv AT lomelioscar theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT pereztorresisrael theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT marquezricardo theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT crialessergio theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT mejiaanam theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT chineyclaudia theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT hernandezlemusenrique theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT sotomariae theevaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT lomelioscar evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT pereztorresisrael evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT marquezricardo evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT crialessergio evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT mejiaanam evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT chineyclaudia evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT hernandezlemusenrique evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients
AT sotomariae evaluationofflowmediatedvasodilationinthebrachialarterycorrelateswithendothelialdysfunctionevaluatedbynitricoxidesynthasemetabolitesinmarfansyndromepatients